Drug Price Increases That Exceed Inflation Are Costing Medicare Part D Billions This AARP Public Policy Institute Spotlight finds that total Medicare Part D spending on 50 top brand-name drugs was $38 billion higher between 2015 and 2019 than it would have been if drug manufac… Read the full article ›